Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2002-07-10
2009-10-20
Aeder, Sean E (Department: 1642)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Reexamination Certificate
active
07604989
ABSTRACT:
The present invention relates to preventing or delaying programmed cell death by expressing one or more anti-apoptotic polypeptides in a cell such that programmed cell death in the cell is prevented or delayed. The present invention also relates to increasing production of a cell-related product by expressing one or more anti-apoptotic polypeptides in a cell such that production of the cell-related product by the cell is increased. Recombinant cells useful for producing cell-related product or cellular therapy are also provided.
REFERENCES:
patent: 5550050 (1996-08-01), Holland et al.
patent: 5811524 (1998-09-01), Brams et al.
patent: 5830698 (1998-11-01), Reff et al.
patent: 5840298 (1998-11-01), Brams et al.
patent: 5866125 (1999-02-01), Brams et al.
patent: 5877210 (1999-03-01), Schieven
patent: 5897992 (1999-04-01), Fearnhead et al.
patent: 5939068 (1999-08-01), Brams et al.
patent: 5955364 (1999-09-01), Brams et al.
patent: 5958765 (1999-09-01), Brams et al.
patent: 5969102 (1999-10-01), Bram et al.
patent: 5998144 (1999-12-01), Reff et al.
patent: 6001358 (1999-12-01), Black et al.
patent: 6011138 (2000-01-01), Reff
patent: 6017733 (2000-01-01), Reff
patent: 6087129 (2000-07-01), Newgard et al.
patent: 6136310 (2000-10-01), Hanna et al.
patent: 6140118 (2000-10-01), Tsai et al.
patent: 6159730 (2000-12-01), Reff
patent: 6512095 (2003-01-01), Baum
patent: 6586206 (2003-07-01), Dixit et al.
patent: 1348758 (2003-01-01), None
patent: 1468079 (2004-10-01), None
patent: WO 00/50453 (2000-08-01), None
Terada et al. “Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle” Cytotechnology, 1997, vol. 25, pp. 17-23.
Goswani et al. (1999, Biotechnology and Bioengineering 62(6):632-40).
Terada et al. (1997, Cytotechnology 25:17-23).
James et al. (2000, Biotechnology and Bioengineering 67(2):134-140).
Luers et al (2000, Eur. J. Cell Biol 79(9):653-7) (abstract only).
Mercille (1999, Biotechnol. Bioeng. 63(5):529-43, abstract only).
Chau et al. (2000, Molecular Cell 6:31-40).
Goswani et al (1999, Biotechnology and Bioengineering 62(6):632-40).
Terada et al (1997, Cytotechnology 25:17-23).
James et al (2000, Biotechnology and Bioengineering 67(2):134-40).
Chau et al (2000, Molecular Cell 6:31-40).
Luers et al (2000, Eur. J. Cell Biol 79(9):653-7).
Figueroa et al (2004, Biotech. Bioeng., 85(6):589-600).
Mercille et al (1999, Biotechnol. Bioeng., 63(5):529-43).
Verma et al. (Nature 1997, 389:239-242).
Amalfitano et al. (Current Gene Therapy 2002, 2: 111-133).
Pandha et al. (Current Opinion in Investigational Drugs 2000; 1 (1): 122-134).
Mader, et al., “A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells”,Proc. Natl. Acad. Sci. USA, 90:5603-5607 (1993).
Elliott, et al., “Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human apithelial tumor cells exposed to etoposide”,Cancer Chemotherapy Pharmacology, 44:1-11 (1999).
Mastrangelo, Alison J., et al. “Part I. Bcl-2 and Bcl-xLLimit Apoptosis upon Infection with Alphavirus Vectors”,Biotechnology and Bioengineering(2000) 67(5):544-554.
Mastrangelo, Alison J., et al. “Part II. Overexpression ofbcl-2Family Members Enhances Survival of Mammalian Cells in Response to Various Culture Insults”,Biotechnology and Bioengineering(2000) 67(5):555-564.
Figueroa, Jr., Bruno, et al. “Comparison of Bcl-2 to a Bcl-2 Deletion Mutant for Mammalian Cells Exposed to Culture Insults”,Biotechnology and Bioengineering(2001) 73(3):211-222.
Figueroa, Jr., Bruno, et al. “Aven and Bcl-xLEnhance Protection Against Apoptosis for Mammalian Cells Exposed to Various Culture Conditions”,Biotechnology and Bioengineering(2001) 85(6):589-600.
Montal, M. “Mitochondria, glutamate nuerotoxicity and the death cascade”,Biochimica et Biophysica Acta(1998) 1366:113-126.
Ricci, J.E., et al. “Récepteurs de surface et signaux intracellulaires impliqués dans la régulation de l'apoptose”,Immuno Analyse et Biologie Specialise, ed. Scientitiques Elsevier, Paris, FR (1998) 13(6):339-349.
Charbonneau, Joel, et al. “Protection of hybrdoma cells against apoptosis by a loop domain-deficient Bcl-xL protein”,Cytotechnology(2001) 37:41-47.
Chiang, Gisela G., et al. “Bcl-xLMediates Increased Production of Humanized Monoclonal Antibodies in Chiense Hamster Ovary Cells”,Biotechnology and Bioengineering(2005) 91(7):779-792.
Figueroa, Jr., Bruno, et al. “A comparison of the properties of a Bcl-XLvariant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures”,Metabolic Engineering(2003) 5:230-245.
Fussenegger, Martin, et al. “Controlled profileration by multigene metabolic engineering ehances the productivity of Chinese hamster ovary cells”,Nature Biotechnology(1998) 16(5):468-472.
González-Garcia, Maribel, et al. “bcl-XLis the majorbcl-xmRNA form expressed during murine development and its product localizes to mitochondria”,Development(1994) 120:3033-3042.
Goswami, J., et al. “Apoptosis in Batch Cultures of Chinese Hamster Ovary Cells”,Biotechnology and Bioengineering(1999) 62(6) 632-640.
Inohara, Naohiro, et al. “Mtd, a Novel Bcl-2 Family Member Activates Apoptosis in the Absence of Heterodimerization with Bcl-2 and Bcl-XL”,The Journal of Biological Chemistry(1998) 273(15):8705-8710.
Kim, No Soo, et al. “Overexpression ofbcl-2Inhibits Sodium Butyrate-Induced Apoptosis in Chinese Hamster Ovary Cells Resulting in Enhanced Humanized Antibody Production”,Biotechnology and Bioengineering(2000/2001) 71(3):184-193.
Mastrangleo, Alison J., et al. “Part I. Bcl-2 and Bcl-xLLimit Apoptosis upon Infection with Alphavirus Vectors”,Biotechnology and Bioengineering(2000) 67(5):544-554.
Mastrangelo, Alison J., et al. “Part II. Overexpression ofbcl-2Family members Enhances Survival of Mammalian Cells in Response to Various Culture Insults”,Biotechnology and Bioengineering(2000) 67(5):555-564.
Meents, Heiko, et al. “Impact of Coexpression and Coamplification of sICAM and Antiapoptosis Determinantsbcl-2/bcl-xLon Productivity, Cell Survival, and Mitochondria Number in CHO-DG44 Grown in Suspension and Serum-Free Media”,Biotechnology and Bioengineering(2002) 80(6):706-716.
Zanghi, James A., et al. “Serum Protects Protein-Free Competent Chinese Hamster Ovary Cells Against Apoptosis Induced by Nutrient Deprivation in Batch Culture”,Biotechnology and Bioengineering(1999) 64(1):108-119.
Ailor Eric
Betenbaugh Michael J.
Figueroa, Jr. Bruno
Hardwick Marie
Reff Mitchell
Aeder Sean E
Biogen Idec Inc.
DLA Piper (LLP) US
Johns Hopkins University
LandOfFree
Inhibition of apoptosis process and improvement of cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of apoptosis process and improvement of cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of apoptosis process and improvement of cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4127011